At MyRNA Diagnostics, we believe that meaningful healthcare innovation happens when science, clinical expertise and industry come together with a shar...
At MyRNA Diagnostics, we believe that meaningful healthcare innovation happens when science, clinical expertise and industry come together with a shared purpose.
This belief recently took an important step forward through our strategic collaboration with IMU University, formalised through the signing of a Memorandum of Understanding (MoU) and Service Agreement on 29 June 2026.
While the signing marked an important milestone, it also reflected a shared commitment to strengthening molecular diagnostics, supporting scientific research and developing the talent needed to advance early cancer detection in Malaysia.
Building a Shared Vision
Since our establishment, MyRNA Diagnostics has been driven by a clear ambition—to build Malaysia's early cancer detection platform anchored on molecular diagnostics, microRNA technology and, ultimately, broader multi-omic diagnostic capabilities.
Achieving this vision requires more than innovative technology. It requires strong partnerships that connect research with real-world healthcare, ensuring scientific discoveries can ultimately benefit patients.
Our collaboration with IMU University is an important step in that journey.
As shared by our General Manager, Dr Mohd Helmi Zakariah, during the signing ceremony:
"Early detection is not just a scientific aspiration. It is a clinical necessity. When cancer is detected earlier, treatment options improve, outcomes improve, cost of care can be reduced, and most importantly, lives can be saved."
This principle continues to guide everything we do from research and innovation to collaboration with partners who share our commitment to improving healthcare outcomes.
Working Together to Strengthen Molecular Diagnostics
Our collaboration with IMU University focuses on three key areas that we believe are essential to building a stronger molecular diagnostics ecosystem.
Developing Future Talent
Innovation begins with people.
Together with IMU University, we look forward to creating opportunities that nurture future talent in molecular diagnostics, laboratory quality, clinical operations, regulatory science and translational health technology. Investing in people today will help strengthen Malaysia's healthcare capabilities for tomorrow.
Advancing Research and Clinical Collaboration
Scientific innovation must be supported by evidence.
Through collaborative research and clinical engagement, we aim to contribute to the generation of local evidence that supports the development and application of molecular diagnostic technologies within the Malaysian healthcare landscape.
Supporting High-Quality Diagnostic Operations
The Service Agreement also formalises IMU University's role as MyRNA Diagnostics' diagnostic partner in supporting important pre-analytical laboratory processes, including sample receipt, sample pre-processing, packaging, documentation and quality assurance before downstream molecular analysis.
Although these processes often happen behind the scenes, they play a vital role in ensuring the integrity and reliability of molecular diagnostic testing.
Looking Ahead
At MyRNA Diagnostics, we see this collaboration as more than a partnership between two organisations. It represents the kind of collaboration needed to translate research into meaningful healthcare solutions.
We are proud to work alongside IMU University in strengthening molecular diagnostics, supporting scientific excellence and contributing to the advancement of early cancer detection in Malaysia.
As we continue to grow, we remain committed to building partnerships that accelerate innovation, develop local capabilities and bring precision diagnostics closer to the patients who need them most.
Discover MyRNA's Innovations
Collaboration is one part of our journey. Innovation is the other.
Our commitment to advancing early cancer detection is reflected in the molecular diagnostic solutions we continue to develop, including LungClear, our flagship microRNA-based solution designed to support the early detection of lung cancer.
Whether you are a healthcare professional, researcher, institutional partner or simply interested in the future of precision medicine, we invite you to learn more about our work and how we are helping shape the next generation of molecular diagnostics.
Explore our solutions: https://myrna.my/solutions
Learn more about LungClear: https://myrna.my/solutions/lungclear
Interested in collaborating with us?
We welcome opportunities to work with healthcare providers, researchers, academic institutions and industry partners who share our vision of advancing precision diagnostics and improving patient outcomes.
